Original Research
Published on 30 Nov 2022
Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients
in Vaccines and Molecular Therapeutics
- 2,937 views
- 9 citations